FDA Review Of Dental Amalgam - Advisory Panel To Consider Risks To Vulnerable Patients

Editor's Choice
Main Category: Dentistry
Article Date: 12 Jun 2010 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:5 stars

5 (2 votes)

Healthcare Prof:3 stars

3 (2 votes)


The US FDA (Food and Drug Administration) say it is to hold an advisory panel on December 14th-15th to discuss a number of scientific issues that may affect dental amalgam regulation, used for direct filling of carious lesions or structural faults in teeth. The meeting will focus mainly on the possible risk to vulnerable patients, such as pregnant women, young children and fetuses.

Amalgam is used for the treatment of tooth decay. It consists of a mixture of metals, composed of liquid mercury and powdered amalgam alloy, made up mainly of silver, tin and copper.

On July 28, 2009, the FDA issued a final rule that reclassified dental mercury from a class I device to class II, classified dental amalgam as a class II device, and designated special controls for dental amalgam, mercury and amalgam alloy. The special control for the devices is a guidance titled, "Class II Special Controls Guidance Document: Dental Amalgam, Mercury and Amalgam Alloy."

Since that final rule, the FDA has received numerous petitions raising various issues regarding the final rule and special controls.

Concerns raised include: In addition, a recent report on risk assessments issued by the National Academy of Sciences, titled "Science and Decisions: Advancing Risk Assessment, NAP 2009," recommends new approaches to carrying out risk assessments. These may be some of the issues the agency asks the advisory committee to review.

Source: FDA

Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our dentistry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christian Nordqvist. "FDA Review Of Dental Amalgam - Advisory Panel To Consider Risks To Vulnerable Patients." Medical News Today. MediLexicon, Intl., 12 Jun. 2010. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/articles/191580.php>

APA
Christian Nordqvist. (2010, June 12). "FDA Review Of Dental Amalgam - Advisory Panel To Consider Risks To Vulnerable Patients." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/articles/191580.php.

Please note: If no author information is provided, the source is cited instead.


Dentistry

Most Popular Articles



Follow Our Dentistry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Dentistry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »